Symptomatic, functional and quality of life measures of remission in 194 outpatients with schizophrenia followed naturalistically in a 6-month, non-interventional study of aripipra...

por Correll, Christoph U., Brieden, Andreas, Janetzky, Wolfgang
Publicado 2023

BPRS domains, items and subgroups analyses, and CGI-I ratings in pooled data from non-interventional studies of aripiprazole once-monthly in schizophrenia (REACT study)

por Schöttle, Daniel, Janetzky, Wolfgang, Therrien, Francois, Wiedemann, Klaus
Publicado 2023

Effectiveness of aripiprazole once-monthly in schizophrenia patients pretreated with oral aripiprazole: a 6-month, real-life non-interventional study

por Schöttle, Daniel, Janetzky, Wolfgang, Luedecke, Daniel, Beck, Elmar, Correll, Christoph U., Wiedemann, Klaus
Publicado 2018

Correction to: Effectiveness of aripiprazole once-monthly in schizophrenia patients pretreated with oral aripiprazole: a 6-month, real-life non-interventional study

por Schöttle, Daniel, Janetzky, Wolfgang, Luedecke, Daniel, Beck, Elmar, Correll, Christoph U., Wiedemann, Klaus
Publicado 2018

The use of long-acting Aripiprazole in a multi-center, prospective, uncontrolled, open-label, cohort study in Germany: a report on global assessment of functioning and the WHO well...

por Schöttle, Daniel, Janetzky, Wolfgang, Luedecke, Daniel, Beck, Elmar, Correll, Christoph U., Wiedemann, Klaus
Publicado 2020

Improvement of functioning in patients with schizophrenia: real-world effectiveness of aripiprazole once-monthly (REACT study)

por Oluboka, Oloruntoba, Clerzius, Guerline, Janetzky, Wolfgang, Schöttle, Daniel, Therrien, François, Wiedemann, Klaus, Roy, Marc-André
Publicado 2023

Real-world effectiveness of aripiprazole once-monthly REACT study: Pooled analysis of two noninterventional studies

por Schöttle, Daniel, Clerzius, Guerline, Janetzky, Wolfgang, Oluboka, Oloruntoba, Roy, Marc-André, Therrien, François, Wiedemann, Klaus
Publicado 2022